Source: Annual Congress 2005 - Chemotherapy and palliative care
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
M. Pesek, L. Benesova, M. Jelinkova, F. Bruha, P. Mukensnabl (Plzen, Prague, Czech Republic). Evaluation of EGFR mutations and ERCC2 polymorphisms in treatment of non-small cell lung cancer. Eur Respir J 2005; 26: Suppl. 49, 191

Member's Comments

No comment yet.

Related content which might interest you: Arg72Pro P53 gene polymorphism is associated with P53 mutations in non-small cell lung cancer (NSCLC) patients Source: Eur Respir J 2004; 24: Suppl. 48, 78s Year: 2004 Arg72Pro P53 gene polymorphism as a predisposing factor for non-small cell lung cancer (NSCLC) development Source: Eur Respir J 2004; 24: Suppl. 48, 78s Year: 2004 Analysis of XPD gene Lys751Gln polymorphism as predisposing factor for non-small cell lung cancer (NSCLC) development Source: Eur Respir J 2007; 30: Suppl. 51, 131s Year: 2007 TP53 Arg72Pro, GSTM1, GSTP1 Ile105Val and GSTT1 gene polymorphisms as predisposing factors for non-small cell lung cancer (NSCLC) development Source: Annual Congress 2006 - Molecular pathology and genetics of lung cancer Year: 2006 Prognostic value of TP53, KRAS and EGFR mutations in nonsmall cell lung cancer: the EUELC cohort Source: Eur Respir J 2012; 40: 177-184 Year: 2012 Genotyping single-nucleotide polymorphisms (SNP) in ERCC1, XPD, XRCC1, XRCC3 and MDR-1 and CCND-1 genes for response and toxicity prediction in chemotherapy of non small cell lung cancer (NSCLC) Source: Annual Congress 2007 - Biology in thoracic oncology Year: 2007 Arg72Pro and GSTM1 gene polymorphisms increase the risk of non small cell lung cancer (NSCLC) Source: Eur Respir J 2005; 26: Suppl. 49, 92s Year: 2005 Germ-line exon 21 EGFR mutations, V843I and P848L, in nonsmall cell lung cancer patients Source: Eur Respir Rev 2014; 23: 390-392 Year: 2014 Polymorphism in GSTM1, GSTT1, p53 and CCR5 genes and lung cancer progression: relation to p53 and Ki-67 protein expression in tumors of non-small cell lung cancer patients Source: Eur Respir J 2006; 28: Suppl. 50, 810s Year: 2006 Association of -93G®A polymorphism in the hMLH1 gene with susceptibility to and prognosis of non-small cell lung cancer in Taiwan Source: Eur Respir J 2006; 28: Suppl. 50, 151s Year: 2006 Association of polymorphism of the human nm23-H1 gene (NME1) with susceptibility to and severity of non-small cell lung cancer Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology Year: 2007 Investigation of survivin gene polymorphism in non-small cell lung cancer patients (NSCLC) Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012 MTHFR gene polymorphism in nonsmall cell lung cancer Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases Year: 2008 Association between H-RAS T81C genetic polymorphism with non-small cell Lung cancer Source: Virtual Congress 2020 – Biological mechanisms of lung cancer Year: 2020 Influence of common p53 and XRCC1 variant alleles on risk of lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 810s Year: 2006 Clinical relevance of p53 and K-ras mutations in nonsmall cell lung cancer (NSCLC) Source: Eur Respir J 2001; 18: Suppl. 33, 230s Year: 2001 Polymorphisms A1026G and G369C of CDKN1A/p21 and p53 genes in lung cancer Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011 Combined effect of p53 and XRCC1 gene polymorphisms on age-associated lung cancer risk Source: Annual Congress 2008 - Discovery of novel targets in lung disease by means of functional genomics Year: 2008 The analysis of CHEK2 gene mutation in small cell lung cancer Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases Year: 2021 p53 gene mutations in lung cancer in Korean Source: Eur Respir J 2005; 26: Suppl. 49, 327s Year: 2005